Fortress Biotech to Present at H.C. Wainwright 25th Annual Global Investment Conference
MIAMI, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic products and product candidates, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 25th Annual Global Investment Conference on Tuesday, September 12, 2023, at 11:30 a.m. ET. The Company will also attend one-on-one meetings during the conference.
A webcast and subsequent archived replay of the company presentation will be available on the Events page of Fortress’ website under News & Media: www.fortressbiotech.com, for approximately 30 days following the meeting.
About Fortress Biotech
Media Relations Contact:
Building Brands in the Metaverse
Keynote Presentation by Avaya
Learning in the Metaverse: Engaging, Efficient, and Fun